Company / Book Value per Share
MADRIGAL PHARMACEUTICALS, INC. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$27.389
FY2025
5-year range
$11.518 / $37.956
FY2021-FY2025
Trend
-27.8%
vs FY2024
Sector context
#17 of 209
Health Care
What the data says
Among 209 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the top 8% for book value per share. Book Value per Share has fluctuated over the past 10 years, ranging from $6.996 in FY2016 to $37.956 in FY2024.
Based on SEC 10-K filings.
$27.389 in FY2025 with a 5-year CAGR of +12.0%. Top quartile in the Health Care sector.
Improved from $22.391 to $27.389 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +33.5%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
-85.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.0%, indicating consistent growth.
- In FY2025, book value per share decreased 27.8% year-over-year.
- Ranks #17 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.389 | -27.8% |
| FY2024 | $37.956 | +69.5% |
| FY2023 | $22.391 | +94.4% |
| FY2022 | $11.518 | -8.9% |
| FY2021 | $12.645 | -18.7% |
| FY2020 | $15.553 | -42.5% |
| FY2019 | $27.059 | -16.1% |
| FY2018 | $32.236 | +116.6% |
| FY2017 | $14.884 | +112.8% |
| FY2016 | $6.996 | +1517.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026